We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ashish Katta has significant experience in the development of VET training and CRICOS businesses domestically and internationally. He has a successful business career building a variety of businesses ...

(NASDAQ:BILI – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 40,915 shares of the company’s stock ...

Recirculation of bilirubin, and its bacterial reduction products, the urobilinoids, has been postulated and denied 1. The availability of bilirubin labelled with carbon-14 in this Laboratory 2 has ...

During the last three months, 5 analysts shared their evaluations of Bilibili (NASDAQ:BILI), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ...

Bilibili's Q3 Earnings: Revenue Surges As Games Lead the Way, Stock Buyback And More Bilibili Inc (NASDAQ: BILI) reported $1.04B revenue, up 26% YoY, beating analyst estimates. Adjusted EPS missed ...

Clinical recommendations for predictive risk assessment aim to reduce the incidence of severe hyperbilirubinemia and bilirubin encephalopathies while minimizing the risks of unintended harm such ...